Most sold drug EU by 2030

$4568 (-9,55 %) together with $AZN (-1,52 %) is currently developing the drug Datroway (breast cancer). Sales revenues of around € 6 billion are expected by 2030:

https://www.fiercepharma.com/marketing/top-10-most-anticipated-drug-launches-2025#:~:text=It's%20already%20off%20to%20a,out%20last%20year's%20roundup%20here.

What do you think of the share? There is still a dividend and the share price has been down 30% for a year. Irritates me a little. Any opinions?